Capital Research Global Investors
AGN

Capital Research Global Investors’s Allergan Inc AGN Stock Holding History

Capital Research Global Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,794,109
Closed -$2.33B – 459
2014
Q1 		$2.33B Buy
18,794,109
+1,321,576
+8% +$161M 0.84% 25
2013
Q4 		$1.94B Sell
17,472,533
-1,091,367
-6% -$104M 0.72% 35
2013
Q3 		$1.68B Sell
18,563,900
-655,700
-3% -$58.9M 0.66% 38
2013
Q2 		$1.62B Buy
+19,219,600
New +$1.99B 0.69% 35

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors's AGN Position: Q2 2014 in Review

Capital Research Global Investors sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 18,794,109 shares — an estimated $2.33B sold.

Capital Research Global Investors first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $2.33B in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Capital Research Global Investors reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Capital Research Global Investors sold 18,794,109 Allergan Inc shares in Q2 2014, an estimated $2.33B.
  • Capital Research Global Investors first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Capital Research Global Investors's Allergan Inc position peaked at $2.33B in Q1 2014.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Capital Research Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.